The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users

Global Public Health

Volumn 7, Issue 10, 2012, Pages 1080-1094

  Tran, Bach Xuan ^a,b   Ohinmaa, Arto ^a,c   Duong, Anh Thuy ^d   Nguyen, Long Thanh ^d   Vu, Phu Xuan ^e   Mills, Steve ^f   Houston, Stan ^a   Jacobs, Philip ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

^d MINISTRY OF HEALTH   (Viet Nam)

^e HANOI UNIVERSITY OF PUBLIC HEALTH   (Viet Nam)

^f FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

cost effectiveness; drug users; HIV AIDS; methadone; Vietnam

Indexed keywords

ANTIRETROVIRUS AGENT; DIAMORPHINE; METHADONE; OPIATE;

ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DEPENDENCE TREATMENT; HEALTH CARE COST; HEALTH PROGRAM; HEROIN DEPENDENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LONGITUDINAL STUDY; METHADONE TREATMENT; MONTE CARLO METHOD; MORTALITY; OPIATE ADDICTION; OUTCOMES RESEARCH; PILOT STUDY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; VIET NAM;

ANALGESICS, OPIOID; COST-BENEFIT ANALYSIS; HEROIN; HIV INFECTIONS; HUMANS; METHADONE; MONTE CARLO METHOD; OPIATE SUBSTITUTION TREATMENT; PILOT PROJECTS; SUBSTANCE ABUSE, INTRAVENOUS; VIETNAM;

EID: 84870924423     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441692.2012.736259     Document Type: Article

References (42)

1. Bergenstrom, A.M. and Abdul-Quader, A.S. 2010. Injection drug use, HIV and the current response in selected low-income and middle-income countries. AIDS, 24(Suppl. 3): S20-S29. doi:10.1097/01.aids.0000390086.14941.91
2. Briggs, A., Claxton, K. and Sculpher, M. 2006. Decision modelling for health economic evaluation, New York: Oxford University Press.
3. The Commission on AIDS in Asia, 2008. Redefining AIDS in Asia: crafting an effective response [online]. New York: Oxford University Press. Available from: http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/report/2008/20080326_report_commission_aids_en.pdf, [Accessed 1 January 2010].
4. Do, T.N., Nguyen, T.M., Do, M.H., Masaya, K., Dang, T.B., Pham, T.L., Yoshikawa, K., Cao, T.T., Nguyen, T.T., Bui, D.D., Nguyen, V.K., Nguyen, T.L. and Fujita, M. 2012. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam. Clinical infectious diseases, 54(Suppl. 4): S306-S312. doi:10.1093/cid/cir1045
5. Doubilet, P., Begg, C.B., Weinstein, M.C., Braun, P. and McNeil, B.J. 1985. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Medical decision making, 5(2): 157-177. doi:10.1177/0272989X8500500205
6. Drummond, M.F., Sculpher, M.J., Torrance, G.W., O'Brien, B.J. and Stoddart, G.L. 2005. Methods for the economic evaluation of health care programmes, New York: Oxford University Press.
7. Gardner, E.M., Hullsiek, K.H., Telzak, E.E., Sharma, S., Peng, G., Burman, W.J., Macarthur, R.D., Chesney, M., Friedland, G. and Mannheimer, S.B. 2010. Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial. AIDS, 24(3): 395-403. doi:10.1097/QAD.0b013e328335cd8a
8. General Statistics Office, 2010. GDP per capita, 2009 [online]. Available from: www.gso.gov.vn [Accessed 26 June 2011].
9. Gouws, E., White, P.J., Stover, J. and Brown, T. 2006. Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sexually transmitted infections, 82(Suppl. 3): iii51-iii55. doi:10.1136/sti.2006.020164
10. Hammett, T.M., Wu, Z., Duc, T.T., Stephens, D., Sullivan, S., Liu, W., Chen, Y., Ngu, D. and Des Jarlais, D.C. 2008. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction, 103(1): 137-145. doi:10.1111/j.1360-0443.2007.02053.x
11. Health Policy Initiative, 2008. Costs associated with implementing an opioid substitution therapy program for IDUs in Vietnam [online]. Available from: http://www.healthpolicyinitiative.com/Publications/Documents/1078_1_Costs_Associated_with_OST_FINAL_acc.pdf [Accessed 1 January 2011].
12. Jelsma, J., Maclean, E., Hughes, J., Tinise, X. and Darder, M. 2005. An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS care, 17(5): 579-588. doi:10.1080/09540120412331319714
13. Jordan, M.R., Bennett, D.E., Bertagnolio, S., Gilks, C.F. and Sutherland, D. 2008. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites. Antiviral therapy, 13(Suppl. 2): 15-23.
14. Laufer, F. 2005. Thresholds in cost-effectiveness analysis-more of the story. Value health, 8(1): 86-87. doi:10.1111/j.1524-4733.2005.08103.x
15. Lawrinson, P., Ali, R., Buavirat, A., Chiamwongpaet, S., Dvoryak, S., Habrat, B., Jie, S., Mardiati, R., Mokri, A., Moskalewicz, J., Newcombe, D., Poznyak, V., Subata, E., Uchtenhagen, A., Utami, D.S., Vial, R. and Zhao, C. 2008. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction, 103(9): 1484-1492. doi:10.1111/j.1360-0443.2008.02249.x
16. Lucas, G.M., Mullen, B.A., McCaul, M.E., Weidle, P.J., Hader, S. and Moore, R.D. 2007. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS patient care STDS, 21(8): 564-574. doi:10.1089/apc.2006.0192
17. Lucas, G.M., Mullen, B.A., Weidle, P.J., Hader, S., McCaul, M.E. and Moore, R.D. 2006. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical infectious diseases, 42(11): 1628-1635. doi:10.1086/503905
18. Lucas, G.M., Weidle, P.J., Hader, S. and Moore, R.D. 2004. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clinical infectious diseases, 38(Suppl. 5): S409-S413. doi:10.1086/421405
19. Mahy, M., Lewden, C., Brinkhof, M.W., Dabis, F., Tassie, J.M., Souteyrand, Y. and Stover, J. 2010. Derivation of parameters used in spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy. Sexually transmitted infections, 86(Suppl. 2): iii28-iii34.
20. Ministry of Health, 2008. HIV/AIDS estimates and projections 2008-2012. Hanoi: Medical Publishing House.
21. Ministry of Health, 2009. National guidelines on HIV/aids diagnosis, care and treatment. Hanoi: Medical Publishing House.
22. Ministry of Health. 2010a 2009 antiretroviral therapy cohort assessment and HIV drug resistance early warning indicators. Hanoi: Medical Publishing House.
23. Ministry of Health, 2010b. Cost of providing HIV care and treatment services in Vietnam. Hanoi: Medical Publishing House.
24. Ministry of Health, 2010c. Effectiveness evaluation of the pilot program for treatment of opioid dependence with methadone in Hai Phong and Ho Chi Minh cities. Hanoi: Medical Publishing House.
25. Ministry of Health, 2011a. HIV/AIDS estimates and projections 2011-2015-input data. Hanoi: Medical Publishing House.
26. Ministry of Health, 2011b. National HIV/AIDS strategic plan, 2011-2020. Hanoi: Medical Publishing House.
27. Murray, C.J., Evans, D.B., Acharya, A. and Baltussen, R.M. 2000. Development of WHO guidelines on generalized cost-effectiveness analysis. Health economics, 9(3): 235-251. doi:10.1002/(SICI)1099-1050(200004)9:3%3C235::AID-HEC502%3E3.0.CO;2-O
28. Nilsson, J., and Oksen, D.V., 2010. Antiretroviral therapy adherence in Quang Ninh, Vietnam-analyzing results on adherence from a randomized controlled trial [online]. Thesis (BA). Goteborgs University. Available from: http://gupea.ub.gu.se/bitstream/2077/23157/1/gupea_2077_23157_1.pdf [Accessed 1 January 2011].
29. Philips, Z., Bojke, L., Sculpher, M., Claxton, K. and Golder, S. 2006. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics, 24(4): 355-371. doi:10.2165/00019053-200624040-00006
30. Philips, Z., Ginnelly, L., Sculpher, M., Claxton, K., Golder, S., Riemsma, R., Woolacoot, N., and Glanville, J., 2004. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health technology assessment, 8 36, iii-iv, ix-xi, 1-158.
31. Roux, P., Carrieri, M.P., Cohen, J., Ravaux, I., Poizot-Martin, I., Dellamonica, P. and Spire, B. 2009. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical infectious diseases, 49(9): 1433-1440. doi:10.1086/630209
32. Roux, P., Carrieri, M.P., Villes, V., Dellamonica, P., Poizot-Martin, I., Ravaux, I. and Spire, B. 2008. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction, 103(11): 1828-1836. doi:10.1111/j.1360-0443.2008.02323.x
33. The Socialist Republic of Vietnam, 2010. 2010 report. Declaration of commitment on HIV and aids adopted at the 26th United Nations General Assembly Special Session in June 2001 (UNGASS). Hanoi: Medical Publishing House.
34. Tam, V.V., Cuong, D.D., and Tu, C.C., 2010. Dotarv: a randomised controlled trial to assess antiretroviral treatment strategies in relation to adherence, resistance and virological treatment failure. UNAIDS Seminar 06/04/2010 [online]. Available from: http://www.unaids.org.vn/sitee/images/stories/dotarv_presentation_hsph_6_april_2010_eng.pdf [Accessed 1 January 2011].
35. Tran, B.X., Ohinmaa, A., Duong, A.T., Nguyen, L.T., Vu, P.X., Mills, S., Houston, S. and Jacobs, P. 2011a. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics. Drug and alcohol dependence, 125(3): 260-266. doi:10.1016/j.drugalcdep.2012.02.021
36. Tran, B.X., Ohinmaa, A., Duong, A.T., Do, N.T., Nguyen, L.T., Nguyen, Q.C., Mills, S., Jacobs, P. and Houston, S. 2011b. Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS. Quality of life research, 21(4): 613-623. doi:10.1007/s11136-011-9963-y
37. Tran, B.X., Ohinmaa, A., Duong, A.T., Nhan, D.T., Nguyen, L.T., Mills, S., Houston, S. and Jacobs, P. 2011c. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. AIDS care, 24(3): 283-290. doi:10.1080/09540121.2011.608420
38. UNAIDS, 2008. 2008 report on the global AIDS epidemic. UNAIDS/08.25E/JC1510E. Geneva.
39. University of Sheffield, 2000. Decision analytic modelling in the economic evaluation of health technologies. A consensus statement. Consensus conference on guidelines on economic modelling in health technology assessment. Pharmacoeconomics, 17 5, 443-444. doi:10.2165/00019053-200017050-00003
40. WHO, ONODC and UNAIDS, 2004. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Geneva: WHO. Available from: http://www.unodc.org/documents/hiv-aids/Position%20Paper%20sub.%20maint.%20therapy.pdf [Accessed 1 January 2012].
41. WHO, UNAIDS and UNICEF, 2010. Towards universal access: setting priority HIV/AIDS interventions in the health sector. Progress Report 2010. Geneva: WHO. Available from: http://www.who.int/hiv/mediacentre/universal_access_progress_report_en.pdf [Accessed 1 January 2012].
42. World Health Organization, 2006. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach-2006 rev. Geneva: WHO.